# Improvement of Humoral Immune Response With Hemodialysis on BK-F Membrane: Correlation to Soluble CD40 Clearing

> **NCT01066559** · NA · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 27 (actual)

## Conditions studied

- Chronic Renal Failure
- Humoral Immune Alterations

## Interventions

- **PROCEDURE:** High flux polymethylmetacrylate membrane
- **PROCEDURE:** Polysulfone membrane
- **BIOLOGICAL:** Hepatitis B serological control
- **BIOLOGICAL:** Seric sCD40 level

## Key facts

- **NCT ID:** NCT01066559
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2015-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01066559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01066559, "Improvement of Humoral Immune Response With Hemodialysis on BK-F Membrane: Correlation to Soluble CD40 Clearing". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01066559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*